Nykode Therapeutics AS (NYKD.OL)
NOK 2.47
(-0.72%)
NOK 2.47
(-0.72%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 58.15 Million USD | 7.1% |
| 2022 | 54.29 Million USD | -14.12% |
| 2021 | 63.22 Million USD | 2500.24% |
| 2020 | 2.43 Million USD | 207.46% |
| 2019 | 790.85 Thousand NOK | 0.0% |
| 2018 | - NOK | 0.0% |
| 2017 | - NOK | 0.0% |
| 2016 | - NOK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 4.78 Million USD | -6.72% |
| 2024 Q1 | 55.66 Million USD | -10.39% |
| 2023 FY | 58.15 Million USD | 7.1% |
| 2023 Q4 | 58.15 Million USD | -5.73% |
| 2023 Q3 | 61.68 Million USD | -5.27% |
| 2023 Q2 | 65.11 Million USD | 12.98% |
| 2023 Q1 | 57.63 Million USD | 6.14% |
| 2022 Q3 | 56.34 Million NOK | -4.83% |
| 2022 Q4 | 54.29 Million USD | -3.64% |
| 2022 Q2 | 59.2 Million NOK | -3.11% |
| 2022 Q1 | 61.11 Million NOK | -3.35% |
| 2021 Q4 | 63.22 Million NOK | 11043.3% |
| 2021 Q3 | 567.4 Thousand NOK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Arctic Bioscience AS | 2.04 Million NOK | -2738.419% |
| Aqua Bio Technology ASA | 7.12 Million NOK | -716.369% |
| ArcticZymes Technologies ASA | 12.58 Million NOK | -361.923% |
| BerGenBio ASA | 418 Thousand NOK | -13811.851% |
| Hofseth BioCare ASA | 136.78 Million NOK | 57.488% |
| PCI Biotech Holding ASA | 319 Thousand NOK | -18129.322% |
| Thor Medical ASA | - NOK | -Infinity% |
| Ultimovacs ASA | 3.71 Million NOK | -1466.16% |